Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis
Xuan-li Chen1, Kai-huan Ren, Hong-wei He
1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
It has been reported that tetrandrine induces cell cycle arrest and apoptosis in human cancer cells. In the present study, we investigated the role of PI3K/AKT/GSK3beta pathway in tetrandrine- induced G(1) arrest and apoptosis. In HT-29 cells, tetrandrine induced dephosphorylation of AKT, activation and nuclear translocation of GSK3beta as well as upregulation of p27(kip1). Activation of GSK3beta via AKT inhibitoion induced by tetrandrine resulted in enhanced phosphorylation and proteolysis of cyclin D(1), activation of caspase 3 and subsequent cleavage of PARP. Selective GSK3beta inhibitiors and GSK3beta siRNA attenuated tetrandrine-induced G(1) arrest and apoptosis. Similar to tetrandrine, transfection of wild-type GSK3beta led to G(1) arrest and apoptosis via downregulation of cyclin D(1) and cleavage of PARP. These findings suggest that tetrandrine induces G(1) arrest and apoptosis through PI3K/AKT/GSK3beta pathway and identify GSK3beta as an important mediator in the processes.
Insights
Tetrandrine triggers cancer cell death by halting the cell cycle and inducing apoptosis. This study reveals the phosphoinositide 3-kinase/AKT/glycogen synthase kinase-3 beta (PI3K/AKT/GSK3β) pathway is crucial for these effects.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tetrandrine is known to induce cell cycle arrest and apoptosis in human cancer cells.
- The PI3K/AKT/GSK3β signaling pathway plays a critical role in cell proliferation, survival, and apoptosis.
Purpose of the Study:
- To investigate the role of the PI3K/AKT/GSK3β pathway in tetrandrine-induced G1 arrest and apoptosis.
- To elucidate the molecular mechanisms underlying tetrandrine's anti-cancer effects.
Main Methods:
- Utilized HT-29 human colon cancer cells.
- Analyzed protein expression and phosphorylation levels (AKT, GSK3β, p27kip1, cyclin D1).
- Assessed apoptosis markers (caspase 3, PARP cleavage) and cell cycle progression.
- Employed selective GSK3β inhibitors and small interfering RNA (siRNA) for GSK3β knockdown.
- Transfected cells with wild-type GSK3β.
Main Results:
- Tetrandrine induced AKT dephosphorylation and GSK3β activation/nuclear translocation in HT-29 cells.
- Tetrandrine upregulated p27kip1, leading to cyclin D1 phosphorylation and proteolysis.
- GSK3β activation by tetrandrine promoted caspase 3 activation and PARP cleavage, key events in apoptosis.
- Inhibition or knockdown of GSK3β attenuated tetrandrine-induced G1 arrest and apoptosis.
- Overexpression of GSK3β mimicked tetrandrine's effects, inducing G1 arrest and apoptosis.
Conclusions:
- Tetrandrine induces G1 cell cycle arrest and apoptosis in human cancer cells via the PI3K/AKT/GSK3β signaling pathway.
- GSK3β acts as a critical mediator in the anti-cancer effects of tetrandrine.
- Targeting GSK3β may represent a therapeutic strategy for cancer treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
